Table 1.
Description of patients evaluated in this study.
Treatment Site | PTV1 Rx | PTV2 Rx | PTV3 Rx | Fractions |
---|---|---|---|---|
Supraglottis | 70 Gy | 56 Gy | N/A | 35 |
Base of Tongue | 70 Gy | 56 Gy | N/A | 35 |
Soft Palate | 70 Gy | 56 Gy | N/A | 35 |
Nasopharynx | 70 Gy | 60 Gy | 54 Gy | 33 |
Oropharynx | 70 Gy | 60 Gy | 54 Gy | 33 |
Larynxa | 70 Gy | 60 Gy | 54 Gy | 35 |
The Larynx patient was not treated at our institution and the Rx was defined for the purposes of this study to match our clinical protocols.